- Home
- ONTO vs CYTK Comparison
ONTO vs CYTK Comparison
Compare ONTO & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONTO
- CYTK
- Stock Information
- Founded
- ONTO 1940
- CYTK 1997
- Country
- ONTO United States
- CYTK United States
- Employees
- ONTO N/A
- CYTK N/A
- Industry
- ONTO Industrial Machinery/Components
- CYTK Biotechnology: Pharmaceutical Preparations
- Sector
- ONTO Industrials
- CYTK Health Care
- Exchange
- ONTO Nasdaq
- CYTK Nasdaq
- Market Cap
- ONTO 6.1B
- CYTK 5.6B
- IPO Year
- ONTO N/A
- CYTK 2004
- Fundamental
- Price
- ONTO $90.53
- CYTK $32.43
- Analyst Decision
- ONTO Strong Buy
- CYTK Buy
- Analyst Count
- ONTO 9
- CYTK 19
- Target Price
- ONTO $203.75
- CYTK $77.33
- AVG Volume (30 Days)
- ONTO 931.4K
- CYTK 2.4M
- Earning Date
- ONTO 05-08-2025
- CYTK 05-06-2025
- Dividend Yield
- ONTO N/A
- CYTK N/A
- EPS Growth
- ONTO 65.04
- CYTK N/A
- EPS
- ONTO 4.06
- CYTK N/A
- Revenue
- ONTO $987,321,000.00
- CYTK $19,218,000.00
- Revenue This Year
- ONTO $13.24
- CYTK $55.84
- Revenue Next Year
- ONTO $9.12
- CYTK $646.96
- P/E Ratio
- ONTO $31.23
- CYTK N/A
- Revenue Growth
- ONTO 21.02
- CYTK 412.21
- 52 Week Low
- ONTO $98.21
- CYTK $31.67
- 52 Week High
- ONTO $238.93
- CYTK $68.44
- Technical
- Relative Strength Index (RSI)
- ONTO 30.62
- CYTK 33.00
- Support Level
- ONTO $120.62
- CYTK $31.67
- Resistance Level
- ONTO $129.77
- CYTK $43.51
- Average True Range (ATR)
- ONTO 4.95
- CYTK 1.93
- MACD
- ONTO -0.70
- CYTK -0.70
- Stochastic Oscillator
- ONTO 2.65
- CYTK 10.56
About ONTO Onto Innovation Inc.
Onto Innovation Inc is engaged in the design, development, manufacture, and support of high-performance control metrology, defect inspection, lithography, and data analysis systems used by microelectronics device manufacturers. The Company and its subsidiaries currently operate in a single operating segment. The company mainly operates in the United States, Southeast Asia, China, Japan, and Europe, with Taiwan and South Korea the sources of total revenue.
About CYTK Cytokinetics Incorporated
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.